Researchers at Virginia Polytechnic Institute and State University took 20 people living with obesity (half on GLP-1s like semaglutide and tirzepatide, half not), and had them drink alcohol while tracking things like blood alcohol levels, blood sugar, and blood pressure over the course of a few hours
This slow but steady decrease is accelerated by sun exposure, stress, poor diet, smoking, pollution, and lack of sleep
Persistent or worsening reactions warrant a clinician check
Its like my brains been rewired
A model that includes only one class of medication narrows the treatment landscape and may discourage the development of diverse, affordable therapeutic options